[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"diabetes-education\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:diabetes-education":32},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,52,87,118,151,184,215,244],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":34,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":46,"leadSponsor":48,"locationsCount":51},"100635720","empowering-faith-based-communities-to-provide-personalized-diabetes-self-management-education-and-support-dsmes-in-the-magic-city-100635720",false,"NCT07556354","Empowering Faith-based Communities to Provide Personalized Diabetes Self-management Education and Support (DSMES) in the Magic City","Empowering Faith-based Communities to Provide Personalized Diabetes Self-management Education and Support (DSMES) in the Magic City: A Pilot Study","MCPILOTDSMES","Inclusion Criteria:\n\n* Have a prior diabetes (Type 1, Type 2, or Gestational) or prediabetes diagnosis\n* Are aged 18 or older\n* Live in Jefferson County, Alabama\n* Have never participated in a DSMES program\n\nExclusion Criteria:\n\n* Not a resident of Jefferson County, Alabama\n* Completed a DSMES program",true,"ALL","18 Years",{"count":21,"type":22},30,"ESTIMATED","INTERVENTIONAL",[25],"NA","In this study, individuals living with diabetes in the Birmingham area will participate in a free, 3-month DSMES program hosted by MedsPLUS Consulting, a local independent pharmacy and wellness center, at a local faith-based organization. DSMES sessions meet twice a month and typically address topics including physical activity, nutrition, coping, and reducing risk and complications. Prior to beginning the program, participants will complete a questionnaire that assesses diabetes self-management behaviors (such as diet, physical activity, and medication adherence) and diabetes knowledge. Additionally, they will participate in a biometric screening where clinical data such as blood A1C, blood pressure, blood cholesterol, and BMI are collected. This data will also be collected again after the completion of the program. In this program, participants will be assigned a community health worker who will contact them outside of scheduled DSMES sessions to provide support. Participants will also be randomly assigned to one of two cohorts, the Traditional cohort and the Remote Patient Monitoring (RPM) cohort. The traditional cohort will use paper trackers to track blood pressure and blood sugar outside of DSMES sessions while the RPM cohort will utilize an RPM platform to track this data.",[28,29,30,31,32,33],"Blood Cholesterol","Blood Pressure Monitoring","Weight Change","BMI","Diabetes Education","Diabetes (DM)",[35,36,37,38],"dsmes","diabetes education","faith based intervention","remote patient monitoring","RECRUITING","2026-06-29",{"date":42,"type":43},"2026-07-01","ACTUAL",{"date":45,"type":22},"2026-07",{"date":47,"type":22},"2026-10",{"name":49,"class":50},"University of Alabama at Birmingham","OTHER",1,{"id":53,"slug":54,"hasResults":11,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":11,"sex":18,"minAge":60,"maxAge":4,"enrollmentInfo":61,"targetDuration":4,"studyType":23,"phases":63,"briefSummary":64,"conditions":65,"keywords":71,"overallStatus":77,"whyStopped":4,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":51},"100628559","integrating-new-skills-into-diabetes-education-with-cgm-100628559","NCT07463209","Integrating New Skills Into Diabetes Education With CGM","Integrating New Skills Into Diabetes Education With CGM (INSIDE-CGM): An Individualized CGM Integration Program for Older Adults With Diabetes","INSIDE-CGM","Participant Inclusion Criteria:\n\n* Adults 65 years and older at time of consent\n* Actively receiving care at a UNC Health or UNC Physicians Network clinic (defined as 2 or more visits in primary care, family medicine, internal medicine, geriatrics, or endocrinology clinics within the past 365 days). Locality for care is defined as residing within a 90-mile radius of UNC Main Hospital on Manning Drive in Chapel Hill, NC.\n* Using any insulin\n* No continuous glucose monitor (CGM) use within the previous 365 days\n* Willing to use a smartphone to access glucose readings using CGM phone app\n* Fluent in English\n\nParticipant Exclusion Criteria:\n\n* Clinical diagnosis of dementia, assessed through chart review and self-report on screening visit (cognitive impairment that is mild and not considered sufficient for diagnosis of dementia is acceptable)\n* Currently receiving dialysis, assessed through chart review and self-report on screening visit\n* Extreme visual or hearing impairment that would impair ability to use real-time CGM or attend and participate in an in-person or virtual group intervention session, assessed at screening visit\n* The presence of a significant medical or psychiatric condition or use of a medication that in the judgment of the investigator may affect completion of any aspect of the protocol, or is likely to be associated with life expectancy of \\\u003C1 year, assessed at screening visit\n* Unavailable for 6-week study duration (such as planned surgery or procedure, planned vacation, etc.) or unwilling to comply with study procedures\n* Not fluent in English\n* Unable to consent to recording of sessions\n\nCare Partner Inclusion Criteria:\n\n* Live in the same household as the study participant\n* Age 18 years or older\n* Fluent in English\n* Be willing to attend sessions alongside the study participant and learn how they can better support their partner participant to manage diabetes\n* Consent to recording of sessions","65 Years",{"count":62,"type":22},144,[25],"This study is designed to test the preliminary efficacy of a three-stage continuous glucose monitor (CGM) integration program for older adults who are taking insulin. This study will learn if a three-stage CGM integration program (\"intervention\") that includes sessions focused on CGM technology skills, data skills, and lifestyle skills impacts CGM wear-time, glycemic metrics, and participant-reported outcomes, compared to two standard CGM training approaches (\"comparators\").\n\nFollowing a screening visit and baseline data collection, participants will be randomized to either the intervention or one of the two comparator arms for 6 weeks. The intervention involves three educational sessions over 4 weeks. The first session will be in-person and subsequent sessions will be virtual. Participants in the intervention may receive 1-2 additional individualized training sessions to review CGM skills. The first comparator (Comparator A) will receive a one-time clinic-based CGM training. The second comparator (Comparator B) will be provided with a comprehensive informational pamphlet about CGM. All participants will complete outcomes data collection at 6 weeks.\n\nThe study will also explore participant experiences through a series of semi-structured interviews with a subset of purposively selected participants and their care partners to identify opportunities for scaling the intervention to a broader population. An extension phase of the study will evaluate long-term CGM use and associated outcomes 3- and 6-months post-intervention.\n\nLastly, we will run an additional small sub-study where consented care partners of participants will attend the intervention or comparator sessions alongside the study participant and provide care partner-specific data.",[66,33,67,32,68,69,70],"Insulin Dependent Diabetes","Diabetes (Insulin-requiring, Type 1 or Type 2)","Diabetes Care","Type 1 Diabetes (T1D)","Type 2 Diabetes Mellitus (T2DM)",[72,73,74,75,76,32],"Continuous Glucose Monitor","Diabetes","Insulin Dependent","Older Adults (65 years and older)","CGM","NOT_YET_RECRUITING","2026-06-23",{"date":80,"type":43},"2026-06-26",{"date":82,"type":22},"2026-06",{"date":84,"type":22},"2028-06",{"name":86,"class":50},"University of North Carolina, Chapel Hill",{"id":88,"slug":89,"hasResults":11,"nctId":90,"briefTitle":91,"officialTitle":92,"acronym":93,"eligibilityCriteria":94,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":95,"targetDuration":4,"studyType":23,"phases":97,"briefSummary":98,"conditions":99,"keywords":102,"overallStatus":77,"whyStopped":4,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":113,"completionDateStruct":114,"leadSponsor":116,"locationsCount":4},"100640071","feasibility-of-a-person-centered-nursing-intervention-on-adherence-and-control-in-patients-with-arterial-hypertension-and-diabetes-mellitus-100640071","NCT07619677","Feasibility of a Person-centered Nursing Intervention on Adherence and Control in Patients With Arterial Hypertension and Diabetes Mellitus.","Feasibility of a Person-centered Nursing Intervention on Adherence and Control in Patients With Arterial Hypertension and Diabetes Mellitus. CERCANO Pilot Trial.","CERCANO pilot","Inclusion Criteria:\n\n1. Adults (18 years or older).\n2. Diagnosis of type 2 diabetes mellitus (DM) or arterial hypertension (HTN) (or both), documented in the medical record.\n3. Prescription of pharmacological treatment for the condition.\n4. Enrollment in a cardiovascular or metabolic risk program and scheduled for a medical follow-up visit within the next 3 to 6 months.\n\nExclusion Criteria:\n\n* Mental disorders that impair autonomy or understanding of the interventions.\n* Congestive heart failure, ischemic or valvular heart disease, end-stage renal disease requiring dialysis, chemotherapy treatment, autoimmune diseases, recent hospitalization due to disease decompensation (within the last month), or any other condition preventing the patient from receiving general health recommendations according to their primary diagnosis.\n* Physical limitations such as quadriplegia, total loss of motor function, or contraindications to physical activity as indicated by medical prescription.",{"count":96,"type":22},100,[25],"Background. Approximately 80% of people with type 2 diabetes mellitus (DM) or arterial hypertension (HTN) do not achieve adequate disease control.\n\nObjective. To evaluate the feasibility of a research study assessing the impact of an educational and nursing counseling intervention with a person-centered care (PCC) approach to improve adherence and control in patients with arterial hypertension and diabetes mellitus in Colombia.\n\nMethods. A pilot randomized controlled clinical trial will be conducted. Adults with DM or HTN enrolled in cardiovascular or metabolic risk programs will be included. A total of 100-200 patients is expected to be recruited. The intervention group will receive counseling and education tailored to their preferences following the PCC approach, while the control group will receive standard care according to the program they belong to. Follow-up will last 6 months, and the primary outcomes to be measured in both groups are: medication adherence, DM control (HbA1c at target levels, change in HbA1c), and HTN control (SBP and DBP at target levels, changes in SBP and DBP).\n\nResults. The findings of this study will provide insight into the feasibility of conducting larger-scale studies to evaluate the effectiveness of PCC-based interventions in Colombia.",[100,32,101],"Diabete Type 2","Hypertension Arterial",[103,104,105,106,107,108,109],"Person-centered care","Hypertension","Diabetes type 2","Control","Adherence","Nursing interventions","Education","2026-06-01",{"date":112,"type":43},"2026-06-04",{"date":82,"type":22},{"date":115,"type":22},"2027-03",{"name":117,"class":50},"Universidad Autónoma de Bucaramanga",{"id":119,"slug":120,"hasResults":11,"nctId":121,"briefTitle":122,"officialTitle":123,"acronym":4,"eligibilityCriteria":124,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":125,"targetDuration":4,"studyType":23,"phases":127,"briefSummary":128,"conditions":129,"keywords":131,"overallStatus":77,"whyStopped":4,"lastUpdateSubmitDate":142,"lastUpdatePostDateStruct":143,"startDateStruct":145,"completionDateStruct":147,"leadSponsor":149,"locationsCount":51},"100616578","effect-of-narrative-education-on-glycemic-control-in-adults-with-type-2-diabetes-in-primary-care-100616578","NCT07307430","Effect of Narrative Education on Glycemic Control in Adults With Type 2 Diabetes in Primary Care","Effect of a Structured Narrative Education Program on Glycemic Control in Adults With Type 2 Diabetes in Primary Care: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Diagnosis of type 2 diabetes mellitus for at least 1 year\n* HbA1c ≥ 7.0% measured within the last 3 months prior to enrollment\n* Followed in the study family health center and reachable by telephone\n* Able to read and write (or able to complete questionnaires with investigator assistance)\n* Provides written informed consent\n\nExclusion Criteria:\n\n* Type 1 diabetes, gestational diabetes, or secondary diabetes\n* Acute infection or hospitalization within the last 2 weeks\n* Major surgery or blood transfusion within the last 3 months\n* Active malignancy or current systemic steroid\u002Fimmunosuppressive therapy\n* Significant cognitive impairment preventing participation\n* Current participation in another structured diabetes education program",{"count":126,"type":22},226,[25],"Type 2 diabetes is common in primary care, and daily self-care behaviors are essential for achieving blood sugar targets. This randomized, two-arm clinical trial will evaluate whether a structured narrative education program added to usual diabetes care improves glycemic control compared with usual care alone in adults with type 2 diabetes. Eligible participants (age ≥18 years) with suboptimal glycemic control (HbA1c ≥7.0% in the last 3 months) will be randomized 1:1 to either standard care or standard care plus narrative education. The narrative education program will be delivered by a family physician over 3 months and includes two individual face-to-face sessions (approximately 20-30 minutes) at Day 0 and Day 15 and four brief telephone reinforcement calls (approximately 3-5 minutes) on Days 30, 45, 60, and 75.\n\nThe primary outcome is the absolute change in HbA1c from baseline (Day 0) to Day 90. Secondary outcomes include changes in diabetes self-care activities (SDSCA-TR), diabetes-related distress (PAID-5-TR), and body mass index (BMI) from Day 0 to Day 90.",[70,130,32],"Diabetes Self-management",[132,133,134,135,136,137,138,139,140,141],"Primary care","Narrative education","Diabetes self-management","HbA1c","Randomized controlled trial","Self-care behaviors","SDSCA","PAID-5","Family medicine","Behavioral intervention","2025-12-26",{"date":144,"type":43},"2025-12-31",{"date":146,"type":22},"2026-02-15",{"date":148,"type":22},"2026-11-15",{"name":150,"class":50},"Mustafa Kemal University",{"id":152,"slug":153,"hasResults":11,"nctId":154,"briefTitle":155,"officialTitle":156,"acronym":157,"eligibilityCriteria":158,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":159,"enrollmentInfo":160,"targetDuration":4,"studyType":23,"phases":162,"briefSummary":163,"conditions":164,"keywords":168,"overallStatus":77,"whyStopped":4,"lastUpdateSubmitDate":175,"lastUpdatePostDateStruct":176,"startDateStruct":178,"completionDateStruct":180,"leadSponsor":182,"locationsCount":51},"100611476","whatsapp-based-and-family-involved-diabetes-self-management-education-study-100611476","NCT07241078","WhatsApp-Based and Family-Involved Diabetes Self-Management Education Study","The Effect of WhatsApp-Based and Family-Involved Self-Management Education and Support on HbA1c, Family Support, and Self-Management in Individuals With Type 2 Diabetes","WAF-DSMES","Inclusion Criteria: People diagnosed with type 2 diabetes at least six months prior, receiving insulin and\u002For oral antidiabetic therapy, with an HbA1c value of 7% or higher, capable of communicating in Turkish, literate, and possessing the ability to use a smartphone and WhatsApp, as well as having internet access. Participants are required to agree to participate together with a family member who can provide support related to diabetes. Family members involved in the intervention are expected to be able to communicate in Turkish, literate, able to use a smartphone and WhatsApp, have internet access, and reside within reach of the participant with diabetes.\n\n\\-\n\nExclusion Criteria: Individuals will be excluded if they have type 1 diabetes or gestational diabetes, severe cognitive impairment, advanced visual or hearing loss, any condition preventing the use of digital platforms, or communication or language barriers that would hinder participation. Family members will be excluded if they have diabetes, cognitive impairment, advanced visual or hearing loss, inability to use digital tools, or communication and language barriers.\n\n\\-","74 Years",{"count":161,"type":22},88,[25],"The aim of this study is to evaluate the effects of a WhatsApp-based and family-involved self-management education program on self-management, family support, and HbA1c levels among individuals with type 2 diabetes mellitus (T2DM).\n\nHypotheses:\n\n* H1: There will be a significant difference in self-management scores between the intervention group receiving the WhatsApp-based and family-involved self-management education and the control group.\n* H2: There will be a significant difference in HbA1c levels between the intervention group receiving the WhatsApp-based and family-involved self-management education and the control group.\n* H3: There will be a significant difference in family support scores between the intervention group receiving the WhatsApp-based and family-involved self-management education and the control group.\n\nThis randomized controlled trial will be conducted with 44 individuals diagnosed with T2DM who meet the inclusion criteria and one family member per participant (total 88 participants). Eligible patients will be randomly assigned to either the intervention or control group using a computer-generated randomization list.\n\nParticipants (people with diabetes and their family members) in the intervention group will receive a 12-week, WhatsApp-based self-management education program. Educational modules (videos, visuals, and written materials) will be shared separately with each person with diabetes and their participating family member via WhatsApp twice a week. To reinforce learning, a five-question quiz will be sent separately to both the person with diabetes and the family member every Thursday. In addition, a brief follow-up phone call (approximately 10 minutes) will be conducted once a week only with the person with diabetes to review progress and provide feedback. Data collection will occur at baseline and at the end of the 12th week.\n\nParticipants in the control group will continue their routine outpatient follow-ups for three months and complete the same measurement tools at baseline and post-intervention.\n\nData will be collected using the Diabetic Participant Demographic Form, Family Member Demographic Form, Diabetes Self Management Questionnaire, Hensarling's Diabetes Family Support Scale, and the Diabetes Knowledge Scale for Adults. Statistical analyses will be performed using SPSS software. Group comparisons will be analyzed with independent t-tests or Mann-Whitney U tests, and pre-post comparisons with paired t-tests or Wilcoxon tests. A significance level of p\\\u003C0.05 will be used.",[165,166,32,167],"Diabetes Mellitus, Type 2","Diabete Mellitus","Self-management",[169,170,171,172,135,173,174],"diabetes","family involved","WhatsApp based","family support","self management","type 2 diabetes","2025-11-16",{"date":177,"type":43},"2025-11-21",{"date":179,"type":22},"2025-11",{"date":181,"type":22},"2026-11",{"name":183,"class":50},"Koç University",{"id":185,"slug":186,"hasResults":11,"nctId":187,"briefTitle":188,"officialTitle":189,"acronym":190,"eligibilityCriteria":191,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":192,"targetDuration":4,"studyType":23,"phases":194,"briefSummary":195,"conditions":196,"keywords":203,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":208,"lastUpdatePostDateStruct":209,"startDateStruct":211,"completionDateStruct":213,"leadSponsor":214,"locationsCount":51},"100604376","pilot-of-continuous-glucose-monitor-augmented-food-is-medicine-100604376","NCT07148713","Pilot of Continuous Glucose Monitor-Augmented Food Is Medicine","Pilot of a CGM-Augmented Food Is Medicine Intervention","ALIGN","Inclusion Criteria:\n\n* Able to complete study activities in English\n* Aged ≥18 years\n* Type 2 diabetes as defined by self-report and confirmed by ICD-10 codes\n\n  * Chart review will be conducted by the study team and a diagnosis of type 2 diabetes (E.11.xx) from either the problem list or a diagnosis linked to an encounter will be used as confirmation. Discrepancies in diagnosis codes will be resolved by review of provider notes within the past 3 years.\n* HbA1c \\> 8.0% in the last 12 months via point of care or venous measurement. If there are multiple values, the most recent one will be considered.\n* Receiving primary or specialty care within UNC Health as defined by at least one visit with a primary care provider or endocrine provider within the past year\n* Indication of a barrier to healthy eating consisting of report of food insecurity (defined as a score greater or equal to 1.0 on the 6-item USDA Food Security Survey Module (FSSM)) and\u002FOR nutrition insecurity (defined as more often than 'Rarely' on the One-Item Gretchen Swanson Nutrition Screener, OR more often than 'Not Very Hard' on the Two-item Nutrition Security Screener (NSS))\n\n  * Any positive screen on the FSSM, Gretchen Swanson Nutrition Screener, or NSS\n* No plans to move from the area for at least 4 months\n* Willing and able to provide written informed consent and participate in all study activities\n\nExclusion Criteria:\n\n* Type 1 or other diabetes\n* Use of insulin or secretagogues in the preceding 6 months\n* Use of CGM in the preceding 6 months\n* Inability to use CGM and related technology (e.g., the companion app), including lack of a smartphone that is compatible with Stelo (information on compatible phones available in Appendix 1) or known allergy to adhesive\n* Known psychosis or major psychiatric illness that prevents participation with study activities\n* Pregnancy or planned pregnancy in the next 4 months-glycemic targets are different for pregnant women compared to non-pregnant women with diabetes and our intervention is designed for non-pregnant glycemic targets\n* Participant in diabetes, nutrition, or weight research intervention in last 12 months",{"count":193,"type":22},60,[25],"This study is designed to test the feasibility and preliminary efficacy of a continuous glucose monitor (CGM)-augmented food is medicine (FIM) intervention for adults with type 2 diabetes and nutrition or food insecurity. This study will learn if a FIM intervention (\"intervention\") that includes access to real-time CGM and nutrition counseling can increase engagement, improve glycemic management, and support healthy eating in this population, compared to the FIM intervention alone (\"comparator\").\n\nAt the study baseline, participants will be randomized to either the intervention or the comparator arm for 16 weeks. The intervention will occur during the first 12 weeks (phase 1: intervention phase) and will be compared to a standard FIM approach without CGM or counseling. Phase 2 (extension phase) will last 4 weeks and will consist of all participants in the intervention and comparator arm receiving both FIM and CGM for self-directed use. The study will also explore participant experiences through a series of semi-structured interviews with a subset of randomly selected participants to identify opportunities for scaling the intervention to a broader population.",[197,198,199,200,32,201,202],"Nutrition","Type 2 Diabetes","T2DM","T2DM (Type 2 Diabetes Mellitus)","Diabetes Type 2","Diabetes Mellitis",[73,199,197,204,205,198,206,207],"Food is Medicine","Continuous glucose monitor","Food insecurity","Nutrition insecurity","2025-11-10",{"date":210,"type":43},"2025-11-12",{"date":212,"type":43},"2025-09-19",{"date":82,"type":22},{"name":86,"class":50},{"id":216,"slug":217,"hasResults":11,"nctId":218,"briefTitle":219,"officialTitle":220,"acronym":4,"eligibilityCriteria":221,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":222,"targetDuration":4,"studyType":23,"phases":224,"briefSummary":225,"conditions":226,"keywords":228,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":235,"lastUpdatePostDateStruct":236,"startDateStruct":238,"completionDateStruct":240,"leadSponsor":242,"locationsCount":51},"100507940","impact-of-a-diabetes-education-mobile-web-application-on-patients-with-uncontrolled-type-2-diabetes-100507940","NCT05893927","Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes","Evaluating the Clinical Impact of a PCP Developed Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Diagnosis of Type 2 Diabetes with HA1c \\>8.0\n* Current patients of the Family Healthcare Center, Reading Hospital Tower health.\n\nExclusion Criteria:\n\n* Identified special populations (pregnancy or individuals currently incarcerated)\n* Patients without access to their own smart phone\n* Any patient who is unable to provide their own informed consent to participate in the study",{"count":223,"type":22},65,[25],"The goal of this clinical trial is to evaluate the use and effectiveness of a mobile web application (app) that is designed to educate and allow patients to manage diabetes and make sustainable lifestyle changes, and to study the impact of the app on clinical outcomes of diabetes (HA1C) and educational outcomes (Self-Efficacy for Diabetes Scale). The main question to answer is: Does the use of the Diabetes Application significantly affect clinical outcomes of diabetes and cardiometabolic risk factors (BMI and Blood Pressure)? Patients will be enrolled in one of two available arms of the study.\n\nParticipants in the 'intervention arm' will use the app to view educational information presented as videos in the following areas: Healthy Coping, Healthy Eating, Staying Active, Medications (Use and Safety), Problem Solving in Diabetes and Disease Pathophysiology. They will continue routine follow-up care with their primary care physicians during the study.\n\nParticipants in the 'control arm' will continue with their primary care physician in routine follow-up care, as normally scheduled.\n\nResearchers will compare the intervention arm participants to the control arm participants to find out about and compare changes in HA1C, systolic blood pressure, diastolic blood pressure, and body mass index. Groups will also be compared on the basis of self-perceived confidence of managing their diabetes by way of the Diabetes Self Efficacy Scale.",[165,32,227],"Lifestyle Modification",[229,230,231,232,233,234],"Type 2 diabetes","Type II diabetes","uncontrolled type 2 diabetes","hyperglycemia","mobile web application","Diabetes education","2025-07-25",{"date":237,"type":43},"2025-07-30",{"date":239,"type":43},"2024-02-15",{"date":241,"type":22},"2026-09-30",{"name":243,"class":50},"The Reading Hospital and Medical Center",{"id":245,"slug":246,"hasResults":11,"nctId":247,"briefTitle":248,"officialTitle":249,"acronym":4,"eligibilityCriteria":250,"healthyVolunteers":17,"sex":18,"minAge":251,"maxAge":252,"enrollmentInfo":253,"targetDuration":4,"studyType":23,"phases":254,"briefSummary":255,"conditions":256,"keywords":258,"overallStatus":77,"whyStopped":4,"lastUpdateSubmitDate":265,"lastUpdatePostDateStruct":266,"startDateStruct":268,"completionDateStruct":270,"leadSponsor":272,"locationsCount":51},"100557250","the-effect-of-kamishibai-diabetes-education-on-knowledge-hba1c-and-quality-of-life-in-children-100557250","NCT06535672","The Effect of Kamishibai Diabetes Education on Knowledge, HbA1c, and Quality of Life in Children","The Effect of Diabetes Education Given to Children Diagnosed With Type 1 Diabetes Mellitus Using the Kamishibai Method on Patients' Knowledge Level, HbA1c Parameter, and Quality of Life: A Randomized Controlled Trial","Inclusion Criteria:\n\n* The child is 8-12 years old.\n* Diagnosed with Type 1 Diabetes Mellitus (T1DM) for at least 1 year.\n* Followed up on an outpatient basis.\n* The child is using insulin.\n* The child can understand and speak Turkish.\n\nExclusion Criteria:\n\n* Presence of another chronic disease other than T1DM that may affect glycemic control.\n* Using an insulin pump.\n* Having vision and\u002For hearing problems.\n* Having a mental and\u002For neurological problem.\n* Having a diagnosis of a psychiatric disease.","8 Years","12 Years",{"count":193,"type":22},[25],"Children diagnosed with Type 1 Diabetes Mellitus (T1DM) initially receive intensive education with their families. Studies indicate that over time, this initial education becomes routine, reducing its effectiveness and failing to adequately address developmental stages, thus requiring repetition. Current methods involve long and intensive educational sessions in hospitals using the Childhood Diabetes Education Guide. These extended, non-interactive sessions often lead to a loss of motivation, decreased learning efficiency, and negative attitudes among patients and their families.\n\nThis study aims to develop an educational tool utilizing the Kamishibai method specifically for children with T1DM aged 8-12. The Kamishibai method is designed to align with their cognitive and sensory development, promoting effective and engaging learning experiences for diabetic patients. By incorporating interactive and visually stimulating elements, Kamishibai seeks to enhance motivation and retention of diabetes education.\n\nHypothesis 1: Children diagnosed with Type 1 DM have higher knowledge levels in the group educated with the Kamishibai method compared to those receiving routine education.\n\nHypothesis 2: The Hemoglobin A1c parameter is lower in the Kamishibai-educated group.\n\nHypothesis 3: The quality of life is higher in the Kamishibai-educated group.\n\nThis study will assess the effectiveness of the Kamishibai method by comparing it to routine educational approaches. The detailed protocol includes technical aspects of the intervention, measurement tools, data collection methods, and statistical analysis plans to ensure a comprehensive evaluation of the method's impact on knowledge levels, HbA1c parameters, and quality of life.",[257],"DIABETES EDUCATION",[259,260,261,262,263,264],"Type 1 Diabetes Mellitus (Type 1 DM)","Kamishibai method","Hemoglobin A1c (HbA1c)","Pediatric diabetes education","Quality of life in children","Randomized controlled tria","2024-07-30",{"date":267,"type":43},"2024-08-02",{"date":269,"type":22},"2024-08-10",{"date":271,"type":22},"2025-07-15",{"name":273,"class":50},"Okan University"]